Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment (Q38259616)

1 September 2017

Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment (English)

1 reference

1 September 2017

Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment (English)

0 references

0 references

Samir Dalia

1

1 reference

1 September 2017

Elizabeth Sagatys

series ordinal

2

1 reference

1 September 2017

Lubomir Sokol

series ordinal

3

1 reference

1 September 2017

Timothy Kubal

series ordinal

4

1 reference

1 September 2017

1 October 2014

1 reference

1 September 2017

October 2014

0 references

published in

Cancer Control

1 reference

1 September 2017

21

1 reference

1 September 2017

322-327

1 reference

1 September 2017

4

1 reference

Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case

1 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Orbital Rosai-Dorfman disease: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Rosai-Dorfman disease of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Intrathoracic Rosai-Dorfman disease with spontaneous remission: a clinical report and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

The Rosai-Dorfman disease histiocytes are not infected by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Extranodal rosai-dorfman disease associated with increased numbers of immunoglobulin g4 plasma cells involving the colon: case report with literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Rosai-Dorfman disease: a retrospective analysis of 13 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Potential clinical implications of BRAF mutations in histiocytic proliferations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Rosai-Dorfman disease with spontaneous resolution: case report of a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Radiotherapy for steroid-resistant laryngeal Rosai-Dorfman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

A case of orbital Rosai-Dorfman disease responding to radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Rosai-Dorfman disease: successful long-term results by combination chemotherapy with prednisone, 6-mercaptopurine, methotrexate, and vinblastine: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

An unusual co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: report of a case and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

"Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481402100408

10.1177/107327481402100408

21 January 2018

Identifiers

DOI

0 references

1 reference